Halozyme Therapeutics, Inc. (HALO) Price History & Returns
How Halozyme Therapeutics, Inc. (HALO) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $125.63 sits 100% of the way up a 52-week range of $61.23 to $125.66; a beta of 0.88 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
13 of 22 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 17 of 36 months closed higher than the month before. Each figure is the last close in that month.
Halozyme Therapeutics, Inc. (HALO) price history — frequently asked questions
How has Halozyme Therapeutics, Inc. performed over the last year?
Halozyme Therapeutics, Inc. (HALO) has risen 82.2% over the last twelve months, measured on price alone.
What is Halozyme Therapeutics, Inc.'s five-year return?
Over five years the HALO share price has gained 201.0%, excluding dividends.
What is Halozyme Therapeutics, Inc.'s 52-week range?
Over the last year Halozyme Therapeutics, Inc. (HALO) has traded between $61.23 and $125.66.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.